Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Kiniksa Pharmaceuticals International, Plc (KNSA) since 2018 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Kiniksa Pharmaceuticals International, Plc. (See page 1 of this report.) Table 2 shows the detailed insider transactions. This company's CIK number is 1730430.
Total stock buying since 2018: $71,686,922.
Total stock sales since 2018: $57,897,366.
Total stock option exercises since 2018: $16,011,786.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2025 | 0 | $0 | 1,033,860 | $30,398,872 | 1,247,324 | $12,850,619 |
| 2024 | 0 | $0 | 654,725 | $15,740,799 | 660,408 | $2,361,930 |
| 2023 | 0 | $0 | 67,316 | $1,241,524 | 201,800 | $237,186 |
| 2022 | 0 | $0 | 21,959 | $354,637 | 72,221 | $34,914 |
| 2021 | 0 | $0 | 58,636 | $1,349,188 | 26,925 | $42,810 |
| 2020 | 0 | $0 | 421,624 | $8,812,346 | 232,661 | $450,847 |
| 2019 | 0 | $0 | 0 | $0 | 18,000 | $33,480 |
| 2018 | 3,912,796 | $71,686,922 | 0 | $0 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2024-10-15 | Tessari Eben (CHIEF OPERATING OFFICER) | Sale | 17,000 | 26.87 | 456,790 |
| 2024-10-15 | Tessari Eben (CHIEF OPERATING OFFICER) | Option Ex | 10,000 | 1.59 | 15,900 |
| 2024-10-04 | Megna Michael R (CHIEF ACCOUNTING OFFICER) | Option Ex | 175 | .00 | 0 |
| 2024-09-23 | Tessari Eben (CHIEF OPERATING OFFICER) | Sale | 17,500 | 24.99 | 437,325 |
| 2024-09-23 | Tessari Eben (CHIEF OPERATING OFFICER) | Option Ex | 10,000 | 1.59 | 15,900 |
| 2024-09-03 | Moat Ross (CHIEF COMMERCIAL OFFICER) | Sale | 68,506 | 26.61 | 1,822,944 |
| 2024-09-03 | Moat Ross (CHIEF COMMERCIAL OFFICER) | Option Ex | 68,506 | 10.63 | 728,424 |
| 2024-09-03 | Paolini John F. (CHIEF MEDICAL OFFICER) | Sale | 60,692 | 26.61 | 1,615,014 |
| 2024-09-03 | Paolini John F. (CHIEF MEDICAL OFFICER) | Option Ex | 60,692 | 2.83 | 171,758 |
| 2024-09-02 | Tessari Eben (CHIEF OPERATING OFFICER) | Option Ex | 1,964 | .00 | 0 |
| 2024-09-02 | Moat Ross (CHIEF COMMERCIAL OFFICER) | Option Ex | 994 | .00 | 0 |
| 2024-09-02 | Ragosa Mark (CHIEF FINANCIAL OFFICER) | Option Ex | 1,861 | .00 | 0 |
| 2024-09-02 | Paolini John F. (CHIEF MEDICAL OFFICER) | Option Ex | 1,725 | .00 | 0 |
| 2024-09-02 | Patel Sanj K (CHAIRMAN & CEO) | Option Ex | 6,569 | .00 | 0 |
| 2024-09-01 | Tessari Eben (CHIEF OPERATING OFFICER) | Option Ex | 4,499 | .00 | 0 |
| 2024-09-01 | Moat Ross (CHIEF COMMERCIAL OFFICER) | Option Ex | 4,089 | .00 | 0 |
| 2024-09-01 | Ragosa Mark (CHIEF FINANCIAL OFFICER) | Option Ex | 4,444 | .00 | 0 |
| 2024-09-01 | Paolini John F. (CHIEF MEDICAL OFFICER) | Option Ex | 4,121 | .00 | 0 |
| 2024-09-01 | Patel Sanj K (CHAIRMAN & CEO) | Option Ex | 16,474 | .00 | 0 |
| 2024-08-27 | Tessari Eben (CHIEF OPERATING OFFICER) | Sale | 17,500 | 26.91 | 470,925 |
| 2024-08-27 | Tessari Eben (CHIEF OPERATING OFFICER) | Option Ex | 10,000 | 1.59 | 15,900 |
| 2024-07-23 | Ragosa Mark (CHIEF FINANCIAL OFFICER) | Sale | 24,248 | 24.79 | 601,107 |
| 2024-07-23 | Ragosa Mark (CHIEF FINANCIAL OFFICER) | Option Ex | 24,248 | 11.10 | 269,152 |
| 2024-07-23 | Paolini John F. (CHIEF MEDICAL OFFICER) | Sale | 22,000 | 26.59 | 584,980 |
| 2024-07-23 | Paolini John F. (CHIEF MEDICAL OFFICER) | Option Ex | 22,000 | 1.86 | 40,920 |
| 2024-07-23 | Patel Sanj K (CHAIRMAN & CEO) | Sale | 136,124 | 25.10 | 3,417,120 |
| 2024-07-23 | Patel Sanj K (CHAIRMAN & CEO) | Option Ex | 136,124 | 1.59 | 216,437 |
| 2024-06-06 | Mccain Tracey L | Option Ex | 4,373 | .00 | 0 |
| 2024-06-06 | Levy Richard S | Option Ex | 4,373 | .00 | 0 |
| 2024-06-06 | Malley Thomas | Option Ex | 4,373 | .00 | 0 |
| 2024-06-06 | Quart Barry D | Option Ex | 4,373 | .00 | 0 |
| 2024-06-06 | Cole G Bradley | Option Ex | 4,373 | .00 | 0 |
| 2024-06-06 | Popovits Kimberly J | Option Ex | 4,373 | .00 | 0 |
| 2024-04-26 | Ragosa Mark (CHIEF FINANCIAL OFFICER) | Option Ex | 991 | .00 | 0 |
| 2024-04-08 | Tessari Eben (CHIEF OPERATING OFFICER) | Option Ex | 2,726 | .00 | 0 |
| 2024-04-08 | Moat Ross (CHIEF COMMERCIAL OFFICER) | Option Ex | 2,477 | .00 | 0 |
| 2024-04-08 | Ragosa Mark (CHIEF FINANCIAL OFFICER) | Option Ex | 2,694 | .00 | 0 |
| 2024-04-08 | Paolini John F. (CHIEF MEDICAL OFFICER) | Option Ex | 2,497 | .00 | 0 |
| 2024-04-08 | Patel Sanj K (CHAIRMAN & CEO) | Option Ex | 9,992 | .00 | 0 |
| 2024-04-08 | Megna Michael R (CHIEF ACCOUNTING OFFICER) | Option Ex | 3,932 | .00 | 0 |
| 2024-04-01 | Moat Ross (CHIEF COMMERCIAL OFFICER) | Option Ex | 1,612 | .00 | 0 |
| 2024-04-01 | Ragosa Mark (CHIEF FINANCIAL OFFICER) | Option Ex | 1,750 | .00 | 0 |
| 2024-04-01 | Paolini John F. (CHIEF MEDICAL OFFICER) | Option Ex | 1,624 | .00 | 0 |
| 2024-04-01 | Patel Sanj K (CHAIRMAN & CEO) | Option Ex | 6,482 | .00 | 0 |
| 2024-04-01 | Megna Michael R (CHIEF ACCOUNTING OFFICER) | Option Ex | 2,558 | .00 | 0 |
| 2024-03-07 | Patel Sanj K (CHAIRMAN & CEO) | Sale | 65,012 | 21.02 | 1,366,552 |
| 2024-03-01 | Tessari Eben (CHIEF OPERATING OFFICER) | Sale | 1,189 | 22.03 | 26,193 |
| 2024-03-01 | Tessari Eben (CHIEF OPERATING OFFICER) | Option Ex | 656 | 1.59 | 1,043 |
| 2024-03-01 | Paolini John F. (CHIEF MEDICAL OFFICER) | Sale | 18,844 | 21.77 | 410,233 |
| 2024-03-01 | Paolini John F. (CHIEF MEDICAL OFFICER) | Option Ex | 18,844 | 1.86 | 35,049 |
| 2024-03-01 | Megna Michael R (CHIEF ACCOUNTING OFFICER) | Sale | 9,659 | 21.45 | 207,185 |
| 2024-03-01 | Megna Michael R (CHIEF ACCOUNTING OFFICER) | Option Ex | 9,659 | 11.36 | 109,677 |
| 2024-02-28 | Megna Michael R (CHIEF ACCOUNTING OFFICER) | Sale | 5,126 | 21.79 | 111,695 |
| 2024-02-28 | Megna Michael R (CHIEF ACCOUNTING OFFICER) | Option Ex | 5,126 | 8.83 | 45,262 |
| 2024-02-27 | Paolini John F. (CHIEF MEDICAL OFFICER) | Sale | 10,156 | 21.03 | 213,580 |
| 2024-02-27 | Paolini John F. (CHIEF MEDICAL OFFICER) | Option Ex | 10,156 | 1.86 | 18,890 |
| 2023-12-19 | Megna Michael R (CHIEF ACCOUNTING OFFICER) | Sale | 9,316 | 19.13 | 178,215 |
| 2023-12-19 | Megna Michael R (CHIEF ACCOUNTING OFFICER) | Option Ex | 9,316 | 13.88 | 129,306 |
| 2023-12-07 | Paolini John F. (CHIEF MEDICAL OFFICER) | Sale | 28,600 | 17.68 | 505,790 |
| 2023-12-07 | Paolini John F. (CHIEF MEDICAL OFFICER) | Option Ex | 28,600 | 1.86 | 53,196 |
| 2023-11-03 | Levy Richard S | Option Ex | 2,777 | .00 | 0 |
| 2023-10-04 | Megna Michael R (CHIEF ACCOUNTING OFFICER) | Option Ex | 175 | .00 | 0 |
| 2023-09-05 | Paolini John F. (CHIEF MEDICAL OFFICER) | Sale | 400 | 17.53 | 7,012 |
| 2023-09-05 | Paolini John F. (CHIEF MEDICAL OFFICER) | Option Ex | 400 | 1.86 | 744 |
| 2023-09-02 | Tessari Eben (CHIEF OPERATING OFFICER) | Option Ex | 1,964 | .00 | 0 |
| 2023-09-02 | Moat Ross (CHIEF COMMERCIAL OFFICER) | Option Ex | 994 | .00 | 0 |
| 2023-09-02 | Ragosa Mark (CHIEF FINANCIAL OFFICER) | Option Ex | 1,861 | .00 | 0 |
| 2023-09-02 | Paolini John F. (CHIEF MEDICAL OFFICER) | Option Ex | 1,725 | .00 | 0 |
| 2023-09-02 | Patel Sanj K (CHAIRMAN & CEO) | Option Ex | 6,569 | .00 | 0 |
| 2023-09-02 | Megna Michael R (CHIEF ACCOUNTING OFFICER) | Option Ex | 774 | .00 | 0 |
| 2023-09-01 | Tessari Eben (CHIEF OPERATING OFFICER) | Option Ex | 2,727 | .00 | 0 |
| 2023-09-01 | Moat Ross (CHIEF COMMERCIAL OFFICER) | Option Ex | 2,477 | .00 | 0 |
| 2023-09-01 | Ragosa Mark (CHIEF FINANCIAL OFFICER) | Option Ex | 2,695 | .00 | 0 |
| 2023-09-01 | Paolini John F. (CHIEF MEDICAL OFFICER) | Option Ex | 2,498 | .00 | 0 |
| 2023-09-01 | Patel Sanj K (CHAIRMAN & CEO) | Option Ex | 9,992 | .00 | 0 |
| 2023-09-01 | Megna Michael R (CHIEF ACCOUNTING OFFICER) | Option Ex | 3,933 | .00 | 0 |
| 2023-07-25 | Paolini John F. (CHIEF MEDICAL OFFICER) | Sale | 29,000 | 18.98 | 550,507 |
| 2023-07-25 | Paolini John F. (CHIEF MEDICAL OFFICER) | Option Ex | 29,000 | 1.86 | 53,940 |
| 2023-06-29 | Mccain Tracey L | Option Ex | 5,000 | .00 | 0 |
| 2023-06-29 | Levy Richard S | Option Ex | 5,000 | .00 | 0 |
| 2023-06-29 | Malley Thomas | Option Ex | 5,000 | .00 | 0 |
| 2023-06-29 | Quart Barry D | Option Ex | 5,000 | .00 | 0 |
| 2023-06-29 | Cole G Bradley | Option Ex | 5,000 | .00 | 0 |
| 2023-06-29 | Popovits Kimberly J | Option Ex | 5,000 | .00 | 0 |
| 2023-04-26 | Ragosa Mark (CHIEF FINANCIAL OFFICER) | Option Ex | 990 | .00 | 0 |
| 2023-04-10 | Tessari Eben (CHIEF OPERATING OFFICER) | Option Ex | 2,727 | .00 | 0 |
| 2023-04-10 | Moat Ross (CHIEF COMMERCIAL OFFICER) | Option Ex | 2,477 | .00 | 0 |
| 2023-04-10 | Ragosa Mark (CHIEF FINANCIAL OFFICER) | Option Ex | 2,695 | .00 | 0 |
| 2023-04-10 | Paolini John F. (CHIEF MEDICAL OFFICER) | Option Ex | 2,498 | .00 | 0 |
| 2023-04-10 | Patel Sanj K (CHAIRMAN & CEO) | Option Ex | 9,992 | .00 | 0 |
| 2023-04-10 | Megna Michael R (CHIEF ACCOUNTING OFFICER) | Option Ex | 3,933 | .00 | 0 |
| 2023-03-20 | Tessari Eben (CHIEF OPERATING OFFICER) | Option Ex | 2,982 | .00 | 0 |
| 2023-03-20 | Moat Ross (CHIEF COMMERCIAL OFFICER) | Option Ex | 2,137 | .00 | 0 |
| 2023-03-20 | Ragosa Mark (CHIEF FINANCIAL OFFICER) | Option Ex | 2,158 | .00 | 0 |
| 2023-03-20 | Paolini John F. (CHIEF MEDICAL OFFICER) | Option Ex | 3,671 | .00 | 0 |
| 2023-03-20 | Patel Sanj K (CHAIRMAN & CEO) | Option Ex | 12,002 | .00 | 0 |
| 2023-03-20 | Megna Michael R (CHIEF ACCOUNTING OFFICER) | Option Ex | 2,163 | .00 | 0 |
| 2023-03-16 | Tessari Eben (CHIEF OPERATING OFFICER) | Option Ex | 1,964 | .00 | 0 |
| 2023-03-16 | Moat Ross (CHIEF COMMERCIAL OFFICER) | Option Ex | 994 | .00 | 0 |
| 2023-03-16 | Ragosa Mark (CHIEF FINANCIAL OFFICER) | Option Ex | 872 | .00 | 0 |
| 2023-03-16 | Paolini John F. (CHIEF MEDICAL OFFICER) | Option Ex | 1,725 | .00 | 0 |
| 2023-03-16 | Patel Sanj K (CHAIRMAN & CEO) | Option Ex | 6,569 | .00 | 0 |
| 2023-03-16 | Megna Michael R (CHIEF ACCOUNTING OFFICER) | Option Ex | 774 | .00 | 0 |
| 2022-11-29 | Quart Barry D | Sale | 21,959 | 16.15 | 354,637 |
| 2022-11-29 | Quart Barry D | Option Ex | 21,959 | 1.59 | 34,914 |
| 2022-03-21 | Tessari Eben (CHIEF OPERATING OFFICER) | Option Ex | 4,611 | .00 | 0 |
| 2022-03-21 | Moat Ross (CHIEF COMMERCIAL OFFICER) | Option Ex | 2,270 | .00 | 0 |
| 2022-03-21 | Ragosa Mark (CHIEF FINANCIAL OFFICER) | Option Ex | 3,019 | .00 | 0 |
| 2022-03-21 | Paolini John F. (CHIEF MEDICAL OFFICER) | Option Ex | 5,676 | .00 | 0 |
| 2022-03-21 | Patel Sanj K (CHAIRMAN & CEO) | Option Ex | 18,555 | .00 | 0 |
| 2022-03-21 | Megna Michael R (CHIEF ACCOUNTING OFFICER) | Option Ex | 3,231 | .00 | 0 |
| 2022-03-16 | Tessari Eben (Chief Operating Officer) | Option Ex | 1,964 | .00 | 0 |
| 2022-03-16 | Moat Ross (Chief Commercial Officer) | Option Ex | 995 | .00 | 0 |
| 2022-03-16 | Ragosa Mark (Chief Financial Officer) | Option Ex | 872 | .00 | 0 |
| 2022-03-16 | Paolini John F. (Chief Medical Officer) | Option Ex | 1,725 | .00 | 0 |
| 2022-03-16 | Patel Sanj K (Chairman & CEO) | Option Ex | 6,569 | .00 | 0 |
| 2022-03-16 | Megna Michael R (Chief Accounting Officer) | Option Ex | 775 | .00 | 0 |
| 2021-02-10 | Patel Sanj K (Chairman & CEO) | Sale | 2,737 | 23.07 | 63,128 |
| 2021-02-10 | Patel Sanj K (Chairman & CEO) | Option Ex | 1,600 | 1.59 | 2,544 |
| 2021-02-09 | Patel Sanj K (Chairman & CEO) | Sale | 43,970 | 23.06 | 1,013,948 |
| 2021-02-09 | Patel Sanj K (Chairman & CEO) | Option Ex | 20,401 | 1.59 | 32,437 |
| 2021-02-08 | Patel Sanj K (Chairman & CEO) | Sale | 9,452 | 23.00 | 217,396 |
| 2021-02-08 | Patel Sanj K (Chairman & CEO) | Option Ex | 4,924 | 1.59 | 7,829 |
| 2021-02-03 | Beetham Thomas W. (EVP & Chief Legal Officer) | Sale | 2,477 | 22.09 | 54,716 |
| 2020-12-31 | Ragosa Mark (Interim CFO) | Option Ex | 4,404 | .00 | 0 |
| 2020-12-31 | Rizvi Qasim (Chief Commercial Officer) | Option Ex | 7,337 | .00 | 0 |
| 2020-10-12 | Patel Sanj K (Chairman & CEO) | Sale | 250,030 | 21.02 | 5,255,630 |
| 2020-10-12 | Patel Sanj K (Chairman & CEO) | Option Ex | 150,700 | 1.59 | 239,613 |
| 2020-10-09 | Patel Sanj K (Chairman & CEO) | Sale | 1,542 | 21.00 | 32,382 |
| 2020-10-09 | Patel Sanj K (Chairman & CEO) | Option Ex | 872 | 1.59 | 1,386 |
| 2020-07-01 | Beetham Thomas W. (EVP & Chief Legal Officer) | Sale | 29,589 | 25.58 | 756,886 |
| 2020-06-10 | Beetham Thomas W. (EVP & Chief Legal Officer) | Sale | 13,752 | 25.07 | 344,762 |
| 2020-06-10 | Beetham Thomas W. (EVP & Chief Legal Officer) | Option Ex | 13,752 | 1.59 | 21,865 |
| 2020-04-21 | Beetham Thomas W. (EVP & Chief Legal Officer) | Sale | 2,518 | 20.00 | 50,360 |
| 2020-04-20 | Beetham Thomas W. (EVP & Chief Legal Officer) | Sale | 47,423 | 19.06 | 903,882 |
| 2020-03-06 | Patel Sanj K (Chairman & CEO) | Sale | 33,115 | 20.00 | 662,300 |
| 2020-02-27 | Paolini John F. (SVP & Chief Medical Officer) | Option Ex | 12,000 | 1.86 | 22,320 |
| 2020-02-20 | Paolini John F. (SVP & Chief Medical Officer) | Sale | 9,803 | 19.11 | 187,384 |
| 2020-02-20 | Paolini John F. (SVP & Chief Medical Officer) | Option Ex | 9,803 | 3.80 | 37,251 |
| 2020-02-19 | Paolini John F. (SVP & Chief Medical Officer) | Sale | 22,477 | 18.27 | 410,654 |
| 2020-02-19 | Paolini John F. (SVP & Chief Medical Officer) | Option Ex | 22,477 | 3.80 | 85,412 |
| 2020-02-14 | Paolini John F. (SVP & Chief Medical Officer) | Sale | 1,039 | 18.33 | 19,044 |
| 2020-02-14 | Paolini John F. (SVP & Chief Medical Officer) | Option Ex | 1,039 | 3.80 | 3,948 |
| 2020-02-14 | Beetham Thomas W. (EVP & Chief Legal Officer) | Sale | 59 | 18.58 | 1,096 |
| 2020-02-13 | Paolini John F. (SVP & Chief Medical Officer) | Sale | 10,277 | 18.29 | 187,966 |
| 2020-02-13 | Paolini John F. (SVP & Chief Medical Officer) | Option Ex | 10,277 | 3.80 | 39,052 |
| 2019-12-05 | Paolini John F. (SVP & Chief Medical Officer) | Option Ex | 8,000 | 1.86 | 14,880 |
| 2019-10-07 | Paolini John F. (SVP & Chief Medical Officer) | Option Ex | 10,000 | 1.86 | 18,600 |
| 2018-05-29 | Cormorant Global Healthcare Master Fund, Lp | Buy | 69,444 | 18.00 | 1,249,992 |
| 2018-05-29 | Deerfield Partners, L.p. | Buy | 843,352 | 19.49 | 16,436,930 |
| 2018-05-29 | Baker Julian (Director) | Buy | 3,000,000 | 18.00 | 54,000,000 |
Insider trading activities including stock purchases, stock sales, and option exercises of KNSA listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Kiniksa Pharmaceuticals International, Plc (symbol KNSA, CIK number 1730430) see the Securities and Exchange Commission (SEC) website.